Diphtheria pathophysiology: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) |
||
| Line 9: | Line 9: | ||
==Overview== | ==Overview== | ||
== | ==Pathopysiology== | ||
[[Diphtheria toxin]] catalyzes the [[ADP-ribosylation]] of, and inactivates, the [[Eukaryotic elongation factors|elongation factor]] eEF-2. In this way, it acts to inhibit [[Translation (biology)|translation]] during eukaryotic protein synthesis. | [[Diphtheria toxin]] catalyzes the [[ADP-ribosylation]] of, and inactivates, the [[Eukaryotic elongation factors|elongation factor]] eEF-2. In this way, it acts to inhibit [[Translation (biology)|translation]] during eukaryotic protein synthesis. | ||
Revision as of 12:58, 2 October 2012
|
Diphtheria Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diphtheria pathophysiology On the Web |
|
American Roentgen Ray Society Images of Diphtheria pathophysiology |
|
Risk calculators and risk factors for Diphtheria pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Pathopysiology
Diphtheria toxin catalyzes the ADP-ribosylation of, and inactivates, the elongation factor eEF-2. In this way, it acts to inhibit translation during eukaryotic protein synthesis.